Ex Vivo Expanded Allogeneic Mesenchymal Stem Cells with Bone Marrow Transplantation Improved Osteogenesis in Infants with Severe Hypophosphatasia
暂无分享,去创建一个
T. Taketani | Mari Sasao | H. Ohgushi | Satoshi Yamamoto | S. Yuba | S. Yamaguchi | Soichiro Yamamoto | S. Yamamoto | K. Hattori | M. Hattori | T. Tadenuma | R. Bo | Hiroe Ohnishi | Yuka Tanabe | Y. Oda | Y. Katsube | R. Kanai | A. Mihara | T. Hirade | Chigusa Oyama | Mariko Abe | Yuko Michibata | M. Sasao | S. Yamaguchi | Yoshihiro Katsube
[1] J. Karp,et al. Mesenchymal stem cells: immune evasive, not immune privileged , 2014, Nature Biotechnology.
[2] H. Kaji. Interaction between Muscle and Bone , 2014, Journal of bone metabolism.
[3] W. Dinjens,et al. Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells , 2014, Experimental biology and medicine.
[4] T. Taketani,et al. Clinical and genetic aspects of hypophosphatasia in Japanese patients , 2013, Archives of Disease in Childhood.
[5] Ajinkya C. Inamdar,et al. Mesenchymal stem cell therapy in lung disorders: Pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell , 2013, Experimental lung research.
[6] D. Harris. Umbilical cord tissue mesenchymal stem cells: characterization and clinical applications. , 2013, Current stem cell research & therapy.
[7] H. Okano,et al. LNGFR+THY-1+VCAM-1hi+ Cells Reveal Functionally Distinct Subpopulations in Mesenchymal Stem Cells , 2013, Stem cell reports.
[8] Xu Cao,et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine , 2013, Nature Medicine.
[9] Nick Bishop,et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. , 2012, The New England journal of medicine.
[10] M. Matthay,et al. Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors , 2011, Stem cells.
[11] C. Niyibizi,et al. Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. , 2010, Bone.
[12] T. Taketani,et al. Restoration of cellular function of mesenchymal stem cells from a hypophosphatasia patient , 2010, Gene Therapy.
[13] M. Whyte. Physiological role of alkaline phosphatase explored in hypophosphatasia , 2010, Annals of the New York Academy of Sciences.
[14] A. Miyawaki,et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow , 2009, The Journal of experimental medicine.
[15] T. Taketani,et al. New bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia. , 2009, The Journal of pediatrics.
[16] L. C. Spolidorio,et al. Effects of long-term FK 506 therapy on the alveolar bone and cementum of rats. , 2009, Transplantation proceedings.
[17] Jeffrey M Karp,et al. Mesenchymal stem cell homing: the devil is in the details. , 2009, Cell stem cell.
[18] D. Niederwieser,et al. Mesenchymal Stem Cells Remain Host-Derived Independent of the Source of the Stem-Cell Graft and Conditioning Regimen Used , 2009, Transplantation.
[19] M. Kassem,et al. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: Current status and future perspectives , 2009, Journal of cellular physiology.
[20] A. Uccelli,et al. Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.
[21] J. Triffitt,et al. Fates and osteogenic differentiation potential of human mesenchymal stem cells in immunocompromised mice. , 2008, European journal of cell biology.
[22] H. Ohgushi,et al. In Vivo Survival and Osteogenic Differentiation of Allogeneic Rat Bone Marrow Mesenchymal Stem Cells (MSCs) , 2008, Cell transplantation.
[23] C. Verfaillie,et al. Self-renewal and differentiation capacity of young and aged stem cells. , 2008, Experimental cell research.
[24] E. Mornet. Hypophosphatasia , 2007, Orphanet journal of rare diseases.
[25] R. Cahill,et al. Infantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblasts. , 2007, The Journal of clinical endocrinology and metabolism.
[26] A. Balas,et al. Mesenchymal Stem Cells are of Recipient Origin in Pediatric Transplantations Using Umbilical Cord Blood, Peripheral Blood, or Bone Marrow , 2007, Journal of pediatric hematology/oncology.
[27] R. Robbins,et al. Stem cell transplantation: the lung barrier. , 2007, Transplantation proceedings.
[28] T. Uemura,et al. [Osteoblastic differentiation and in vivo osteogenic activity of marrow-derived mesenchymal stem cells stimulated by Tacrolimus: experiment with rats]. , 2007, Zhonghua yi xue za zhi.
[29] H. Ohgushi,et al. Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy , 2005, Circulation.
[30] H. Ohgushi,et al. Tissue engineered ceramic artificial joint--ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. , 2005, Biomaterials.
[31] T. Uchihashi,et al. Common mutations F310L and T1559del in the tissue-nonspecific alkaline phosphatase gene are related to distinct phenotypes in Japanese patients with hypophosphatasia , 2005, European Journal of Pediatrics.
[32] H. Ohgushi,et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. , 2004, American journal of physiology. Heart and circulatory physiology.
[33] J. Miyake,et al. In-Situ Visualization and Quantification of Mineralization of Cultured Osteogenetic Cells , 2003, Calcified Tissue International.
[34] J. Kurtzberg,et al. Marrow Cell Transplantation for Infantile Hypophosphatasia , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[35] C. Peters,et al. Hematopoietic cell transplantation for inherited metabolic diseases: an overview of outcomes and practice guidelines , 2003, Bone Marrow Transplantation.
[36] S. Gerson,et al. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) , 2002, Bone Marrow Transplantation.
[37] L. Muul,et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Chopp,et al. Therapeutic Benefit of Intravenous Administration of Bone Marrow Stromal Cells After Cerebral Ischemia in Rats , 2001, Stroke.
[39] W. Koo,et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. , 2001, Blood.
[40] Darwin J. Prockop,et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.
[41] Kazuya Sato,et al. Mesenchymal stromal cells for graft-versus-host disease : basic aspects and clinical outcomes. , 2010, Journal of clinical and experimental hematopathology : JCEH.